Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Feb 5, 2026, 9:30 AM EST
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $5.2 million as of February 6, 2026. Its market cap has decreased by -56.25% in one year.
Market Cap
5.20M
Enterprise Value
6.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 5.20M, a decrease of -95.19%. That is a compound annual growth rate of -8.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 5.20M | 84.70% |
| Dec 31, 2025 | 2.81M | -75.72% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 7.84M |
| Synlogic | 7.43M |
| Brainstorm Cell Therapeutics | 6.62M |
| Orgenesis | 5.90M |
| BetterLife Pharma | 5.86M |
| Bioxytran | 5.50M |
| AXIM Biotechnologies | 4.99M |
| Nymox Pharmaceutical | 4.59M |